Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary (Q33540823)

27 July 2017

1 reference

title

Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary (English)

1 reference

27 July 2017

main subject

Gram-negative bacteria

0 references

author name string

Chow JW

series ordinal

1

1 reference

27 July 2017

Yu VL

series ordinal

2

1 reference

27 July 2017

publication date

1 January 1999

1 reference

International Journal of Antimicrobial Agents

27 July 2017

published in

1 reference

27 July 2017

volume

11

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

7-12

1 reference

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Klebsiella pneumoniae bacteraemia at an urban general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Klebsiella bacteremia. A 10-year review in a cancer institution

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

Risk factors for toxicity in elderly patients given aminoglycosides once daily.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900060-0

7 January 2021

10.1016/S0924-8579(98)00060-0

Identifiers

DOI

1 reference

27 July 2017

1 reference